Literature DB >> 22446350

Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer.

Stefan Tritschler1, Clarissa Mosler, Derya Tilki, Alexander Buchner, Christian Stief, Anno Graser.   

Abstract

OBJECTIVE: To evaluate the agreement between radiologic staging of bladder cancer using multidetector row computed tomography (CT) and histopathologic staging and estimate the influence of interobserver variability of the CT findings as a potential limitation of this imaging modality. The available data on the value of multidetector row CT in clinical staging before cystectomy are controversial.
METHODS: The multidetector row CT reports of all patients undergoing radical cystectomy at our institution from 2004 to 2008 were retrospectively reviewed and compared in a blinded expert review by an experienced abdominal/genitourinary radiologist. The results of both radiologic reviews were subsequently correlated with the pathologic findings of the surgical specimens. The interobserver variability of radiology reports was estimated using κ statistics.
RESULTS: Preoperative CT scans were available for 276 patients who underwent radical cystectomy. The accuracy of the primary and reference radiologists in predicting the correct local tumor stage was 49% (κ 0.23, P < .001) and 51% (κ 0.24, P < .001), respectively. The accuracy in predicting the presence of lymph node metastases was 54% (κ 0.04, P = .297) and 58% (κ 0.15, P = .011). The agreement between both radiologists was fair with regard to the local tumor stage (κ 0.23, P < .001) and the presence of lymph node metastases (κ 0.35, P < .001).
CONCLUSION: The overall agreement between the local bladder cancer stage between CT and pathologic staging was poor to fair. Significant interobserver variability was found in the CT findings that might contribute to the limited accuracy of CT in the detection of extravesical tumor spread, infiltration of extravesical organs, and lymph node involvement.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22446350     DOI: 10.1016/j.urology.2012.01.040

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  Should we spare neoadjuvant chemotherapy in low-risk muscle-invasive bladder cancer patients scheduled for radical cystectomy?

Authors:  Günter Niegisch
Journal:  Transl Androl Urol       Date:  2019-07

2.  Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.

Authors:  Jack Crozier; Nathan Papa; Marlon Perera; Brian Ngo; Damien Bolton; Shomik Sengupta; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2018-08-17       Impact factor: 4.226

3.  Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Huyen T Nguyen; Kamal S Pohar; Guang Jia; Zarine K Shah; Amir Mortazavi; Debra L Zynger; Lai Wei; Daniel Clark; Xiangyu Yang; Michael V Knopp
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

4.  Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival.

Authors:  Sebastian Christoph Schmid; Tina Zahel; Bernhard Haller; Thomas Horn; Ilja Metzger; Konstantin Holzapfel; Anna K Seitz; Jürgen Erich Gschwend; Margitta Retz; Tobias Maurer
Journal:  World J Urol       Date:  2015-08-11       Impact factor: 4.226

5.  Utility of Clinical Risk Stratification in the Selection of Muscle-Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy: A Retrospective Cohort Study.

Authors:  Friedrich-Carl von Rundstedt; Douglas A Mata; Oleksandr N Kryvenko; Anup A Shah; Iny Jhun; Seth P Lerner
Journal:  Bladder Cancer       Date:  2017-01-27

6.  Is Exam under Anesthesia Still Necessary for the Staging of Bladder Cancer in the Era of Modern Imaging?

Authors:  Alexander T Rozanski; Cooper R Benson; Jacob A McCoy; Charles Green; H Barton Grossman; Robert S Svatek; Jay B Shah
Journal:  Bladder Cancer       Date:  2015-04-30

Review 7.  MR-Guided Adaptive Radiotherapy for Bladder Cancer.

Authors:  Adham Hijab; Boris Tocco; Ian Hanson; Hanneke Meijer; Christina Junker Nyborg; Anders Smedegaard Bertelsen; Robert Jan Smeenk; Gillian Smith; Jeff Michalski; Brian C Baumann; Shaista Hafeez
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

8.  Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review.

Authors:  Dawei Wang; Keping Zhang; Lihui Guan; Nuan Wen
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

Review 9.  Advances in bladder cancer imaging.

Authors:  Shaista Hafeez; Robert Huddart
Journal:  BMC Med       Date:  2013-04-10       Impact factor: 8.775

Review 10.  Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer.

Authors:  Isuru S Jayaratna; Neema Navai; Colin P N Dinney
Journal:  Transl Androl Urol       Date:  2015-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.